Stevanato Group S.p.A. (STVN)
NYSE: STVN · IEX Real-Time Price · USD
28.40
-0.46 (-1.59%)
At close: Apr 18, 2024, 4:00 PM
28.77
+0.37 (1.30%)
After-hours: Apr 18, 2024, 7:16 PM EDT
Company Description
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.
The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A.
is a subsidiary of Stevanato Holding S.R.L.
Stevanato Group S.p.A.
Country | Italy |
Founded | 1949 |
IPO Date | Jul 16, 2021 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
Employees | 5,634 |
CEO | Franco Moro |
Contact Details
Address: Piombino Dese (Pd) Via Molinella, 17 Padua, L6 35017 Italy | |
Phone | 39 049 9318173 |
Website | stevanatogroup.com |
Stock Details
Ticker Symbol | STVN |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $21.00 |
CIK Code | 0001849853 |
CUSIP Number | T9224W109 |
ISIN Number | IT0005452658 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Franco Stevanato | Executive Chairman |
Franco Moro | Chief Executive Officer and Director |
Marco Dal Lago | Chief Financial Officer |
Ugo Gay | Chief Operations Officer |
Lorenzo Bendinelli | Chief Information Officer |
Lisa Miles | Senior Vice President of Investor Relations |
Paolo De Fabritiis | Chief Human Resources Officer |
Mauro Stocchi | Chief Business Officer |
Riccardo Butta | President of Americas |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 27, 2024 | 6-K | Report of foreign issuer |
Mar 26, 2024 | 6-K | Report of foreign issuer |
Mar 25, 2024 | 6-K | Report of foreign issuer |
Mar 25, 2024 | 424B5 | Filing |
Mar 21, 2024 | 6-K | Report of foreign issuer |
Mar 20, 2024 | 424B5 | Filing |
Mar 20, 2024 | F-3ASR | Filing |
Mar 15, 2024 | 6-K | Report of foreign issuer |
Mar 7, 2024 | 20-F | Annual and transition report of foreign private issuers |
Mar 7, 2024 | 6-K | Report of foreign issuer |